Some of the major precision Medicine market players are Tepnel Pharma Services, Biocrates Life Sciences, Qiagen, Novartis, NanoString Technologies, Menarini Silicon Biosystems, Pfizer, Eagle Genomics, Roche, Intomics, Quest Diagnostics, and Teva Pharmaceutical.

The North American precision medicine market value surpassed USD 21 billion in 2018 and is set to achieve 9%+ CAGR from 2019 to 2025, on account of favorable government scenario coupled with increased funding for research in precision medicine.

Cancer DNA mutations can now be detected in the blood in femtogram concentrations (one femtogram = one thousand trillionth of a gram)

R-Pharm and GenQual are pleased to announce a new collaboration focused on the development of novel predictive diagnostic tools in the area of Rheumatoid Arthritis and Autoimmune diseases.

HTG Molecular Diagnostics, a privately-held, Tucson-based company providing products for gene expression profiling, miRNA, siRNA and mRNA measurement recently added three professionals to its executive team.

The technology can dramatically accelerate the developing diagnostics for personalized medicine and reduce cost